Key Takeaways Acadia Healthcare is growing steadily, driven by demand for behavioral health services and facility expansion.ACHC added beds and joint ventures, boosting revenue growth and positioning for higher occupancy gains.Rising expenses and weak ROE versus industry peers remain key concerns despite solid growth outlook.Acadia Healthcare Company, Inc. (ACHC) is steadily increasing its business due to rising demand for behavioral health services. Its psychiatric hospitals and treatment centers are perfo ...

A month has gone by since the last earnings report for Acadia Healthcare (ACHC) . Shares have added about 7% in that time frame, outperforming the S&P 500.But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is Acadia Healthcare due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important catalysts.Acadia Heal ...

Core Viewpoint - Acadia Healthcare Company, Inc. has received a consensus recommendation of "Hold" from analysts, with a mixed rating distribution and an average price target of $21.15 [2] Analyst Ratings - Mizuho reduced its price target from $22.00 to $17.00 and maintained a "neutral" rating [3] - Bank of America downgraded its rating from "neutral" to "underperform" and lowered the target price from $21.50 to $13.00 [3] - Guggenheim decreased its target price from $27.00 to $22.00 while maintaining a "buy" rating [3] - Zacks Research upgraded the rating from "strong sell" to "hold" [3] - Cantor Fitzgerald set a price objective of $17.00 [3] Institutional Holdings - Wellington Management Group increased its stake by 24.9%, owning 11,774,308 shares valued at $167.08 million after acquiring 2,350,760 shares [4][5] - Vanguard Group raised its position by 7.8%, now holding 9,417,045 shares worth $233.17 million after an additional purchase of 681,278 shares [4][5] - Goldman Sachs Group increased its holdings by 417.8%, owning 4,728,613 shares valued at $67.10 million after buying 3,815,471 shares [4][5] - Abrams Bison Investments raised its position by 22.3%, now owning 4,380,000 shares worth $108.45 million after purchasing 800,000 shares [4][5] - UBS Group increased its stake by 8.8%, now holding 4,336,698 shares valued at $107.38 million after acquiring 350,484 shares [4][5] Financial Performance - Acadia Healthcare reported an EPS of $0.07 for the last quarter, exceeding the consensus estimate of $0.03 by $0.04 [7] - The company generated revenue of $821.46 million, surpassing the consensus estimate of $800.10 million, with a year-over-year revenue increase of 6.1% [7] - The company has set FY 2026 EPS guidance at 1.300-1.550 and Q1 2026 guidance at 0.250-0.300 [7] Company Overview - Acadia Healthcare, founded in 2005 and headquartered in Franklin, Tennessee, specializes in behavioral healthcare services, focusing on mental health and addiction treatment across the U.S. [8] - The company operates a diversified network that includes inpatient psychiatric hospitals, residential treatment centers, outpatient clinics, and intensive outpatient programs [9]

Is ACHC a good stock to buy? We came across a bullish thesis on Acadia Healthcare Company, Inc. on Valueinvestorsclub.com by ppsm920. In this article, we will summarize the bulls’ thesis on ACHC. Acadia Healthcare Company, Inc.'s share was trading at $23.73 as of March 17th. ACHC’s trailing and forward P/E were 19.82 and 12.44 respectively according to Yahoo Finance. Countries with Lowest Abortion Rates in the World in 2018 Photographee.eu/Shutterstock.com Acadia Healthcare (ACHC) represents a compelling ...

Company Overview - Acadia Healthcare Company, Inc. (ACHC) is positioned as a compelling turnaround opportunity in the U.S. behavioral health sector, characterized by strong long-term supply-demand dynamics and high barriers to entry [2] - The company operates 278 facilities with 12,500 beds across various care levels, addressing critical needs in mental health and opioid addiction [3] Financial Performance - As of March 17th, ACHC's share price was $23.73, with trailing and forward P/E ratios of 19.82 and 12.44 respectively [1] - The market is currently pricing ACHC at roughly 6x forward EBITDA, significantly below its 10-year average of 11x, indicating a perception of permanent impairment despite intact core fundamentals [5] Growth Strategy - Following the sale of its UK business in 2021, Acadia has focused on the U.S. market, growing patient volumes post-Covid and aggressively expanding with thousands of new beds [2] - The company is shifting towards free cash flow generation, with lower capital expenditures and a focus on high-return on invested capital (ROIC) bed additions, which is expected to improve operational efficiency [4] Risk Factors and Market Sentiment - Investor sentiment has been negatively impacted by aggressive expansion, large legal settlements, and a management reset under CEO Chris Hunter, leading to a stock decline of over 80% from its 2024 peak [3] - Despite these challenges, the company could see a potential cash flow increase of $500–550 million due to normalization of labor costs and reduced startup losses [4] Investment Outlook - With modest operational execution and stabilization of guidance, ACHC could offer a 3–4x upside from current levels, presenting a highly asymmetric risk/reward profile in a demand-rich healthcare market [5][6]

Core Insights - Acadia Healthcare has experienced significant leadership changes, with Debbie returning as CEO, bringing over 30 years of experience in the behavioral health industry [2] - The company has added 3,000 new beds across its facilities by the end of the year, indicating a focus on expanding capacity and operational execution [3] Leadership Changes - The return of Debbie as CEO has invigorated the operational team, highlighting her extensive experience and previous tenure at Acadia [2] - Todd Young, the CFO, has been in his role for just over four months and is focused on diagnosing company issues amidst these leadership changes [2] Operational Focus - The primary opportunity for Acadia Healthcare is to fill the newly added beds and enhance operational performance [3] - The emphasis on cultural changes under Debbie's leadership aims to facilitate a turnaround within the organization [2]

Acadia Healthcare Company (NasdaqGS:ACHC) FY Conference Summary Company Overview - **Company**: Acadia Healthcare Company - **Industry**: Behavioral Health Services - **Event**: Barclays Global Healthcare Conference - **Date**: March 10, 2026 Key Points Leadership Changes - **CFO Todd Young** has been in the role for just over 4 months, with **Debbie** returning as CEO, bringing over 30 years of experience in behavioral health [3][4] - The leadership change has invigorated operations, with a focus on filling 3,000 new beds added across facilities [3][4] Financial Performance and Opportunities - **$200 million** embedded EBITDA opportunity exists from facilities opened in the last three years, with underperformance attributed to licensure delays and operational execution issues [4][5] - Current occupancy rates for new facilities are behind expectations, indicating a significant opportunity for profitability improvement [7][8] Growth Projections - **2026 guidance** anticipates approximately **4% growth** in same-store volume, driven by operational execution and expansion of existing facilities [8][9] - Demand for inpatient psychiatric services remains strong, with specialty business growth impacted by facility closures and New York Medicaid policy changes [10][11] Medicaid and Payer Dynamics - New York's policy change restricting out-of-state Medicaid care is expected to create a **$25 million-$30 million** EBITDA headwind in 2026 [19][21] - Increased scrutiny from payers regarding length of stay and denials has been noted, with a stable length of stay expected across the company [14][15] Staffing and Compliance - California's new staffing requirements are projected to result in a **$4 million** EBITDA headwind, with compliance efforts ongoing [23][24] - The company is focused on hiring higher-skilled nurses to meet these requirements without reducing occupancy [23][24] Claims and Safety Investments - A **$61 million** increase in PLGL expenses was reported, driven by a **186%** increase in claims [27][28] - Investments in safety and quality technology are being made to reduce incident risk and improve patient care [30] Capital Deployment and Cash Flow - CapEx is expected to decline by more than **$300 million** in 2026, with positive free cash flow anticipated [31][32] - Priorities for discretionary cash deployment include debt reduction and operational improvements rather than new capital expenditures [31][32] Outpatient Behavioral Opportunities - The company has a significant outpatient business through its CTC division, focusing on integrating outpatient care as part of a continuum of care rather than pursuing a standalone outpatient model [34] Additional Insights - The company is actively working to backfill facilities affected by policy changes and is optimistic about the potential reassessment of New York's Medicaid policy [21][22] - Continuous monitoring of claims and settlement costs is in place to manage financial expectations and mitigate risks [29][30]

Company Overview - Acadia Healthcare Company, Inc. (NASDAQ:ACHC) provides behavioral healthcare services in the United States, operating in various settings such as inpatient mental hospitals, specialty treatment facilities, residential treatment programs, and outpatient clinics [4]. Financial Performance - For the fourth quarter of 2025, Acadia reported revenue of $821.5 million, reflecting a 6.1% increase compared to the previous year. Same-facility revenue rose by 4.4%, driven by a 3.1% increase in patient days and a 1.3% rise in revenue per day [3]. - The company experienced a net loss of $13.02 per diluted share, which included a non-cash goodwill impairment charge of $996.2 million. However, adjusted net income was reported at $6.1 million, or $0.07 per share [3]. - Adjusted EBITDA for the quarter was $99.8 million, with a $52.7 million adjustment to professional and general liability reserves [3]. - Acadia increased its licensed beds by 181 in the quarter and by 1,089 throughout 2025. Revenue is projected to range from $3.37 billion to $3.45 billion in 2026, with adjusted EPS expected to be between $1.30 and $1.55 [3]. Analyst Ratings - On March 2, 2026, Barclays analyst Andrew Mok raised Acadia's price target to $20 from $14 while maintaining an Equal Weight rating [2][7]. - Acadia Healthcare was recognized as one of the 12 Best Performing Stocks in February [1].

Core Insights - Acadia Healthcare is focusing on leadership accountability and organizational structure improvements under CEO Debbie Osteen, aiming to enhance decision-making processes and operational efficiency [1][2][3] Management Focus Areas - The management is prioritizing the right personnel in key roles and clearer accountability, particularly regarding new and joint venture facilities [1] - There is enthusiasm within the organization following Osteen's return as CEO, with a focus on leveraging existing bed capacity for growth without significant new capital investment [2][3] Financial Performance and Projections - Professional liability costs have significantly increased, with PLGL expenses rising by $61 million in 2025 and claims up 186%, leading to a focus on debt reduction and lower capital expenditures in 2026 [4][17] - Acadia is facing payer headwinds, particularly a conservative estimate of $25–$30 million impact from New York Medicaid, with plans to mitigate this through backfilling in New Jersey and Pennsylvania [5][14][15] Capacity and Facility Management - The company aims to ramp up and fill approximately 3,000 newly added beds from 2023 to 2026, with guidance for an additional 400–600 beds, focusing on expanding existing facilities rather than new builds [6][12] - Management believes it has largely completed recent facility closures and is now focused on improving operations and occupancy rates [8] Startup Dynamics and Facility Performance - Young discussed the performance of new facilities, attributing underperformance to overly aggressive expectations and delays in licensure processes [7] - Acadia has several large facilities coming online, with guidance assumptions based on recent history to ensure realistic projections [9][11] Liability and Payer Environment - The company has seen a significant increase in professional liability expenses, with reserves rising to $155 million, and is actively monitoring claims and settlements [16][18] - Managed Medicaid trends are expected to remain stable, with a focus on documentation and advocacy to support payer negotiations [19] Capital Allocation Strategy - Acadia's leverage is approximately 4x, with a priority on debt paydown over share repurchases, and planned capital expenditures are expected to decline significantly in 2026 [20][21]

Core Insights - The company is well-positioned in the market with growing demand for its services and a diversified business model across various healthcare segments [3] Company Operations - The organization has recently welcomed back Debbie Osteen as CEO, whose industry experience and operational expertise have revitalized the employee base [4] - Todd Young, the new CFO, has been with the company for four months and is adapting to the services side of healthcare after a background in product [2] Business Segments - The company operates in multiple areas including acute inpatient, specialty inpatient, residential, and outpatient services, particularly focusing on opioid replacement therapy known as CTC [3]